Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Role of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1
Eric O'Neill,1Linda Rushworth,1Manuela Baccarini,3Walter Kolch1,2*
The ablation of the protein kinase Raf-1 renders cells hypersensitiveto apoptosis despite normal regulation of extracellular signalregulatedkinases, which suggests that apoptosis protection is mediatedby a distinct pathway. We used proteomic analysis of Raf-1 signalingcomplexes to show that Raf-1 counteracts apoptosis by suppressingthe activation of mammalian sterile 20like kinase (MST2).Raf-1 prevents dimerization and phosphorylation of the activationloop of MST2 independently of its protein kinase activity. Depletionof MST2 from Raf-1/ mouse or human cells abrogatedsensitivity to apoptosis, whereas overexpression of MST2 inducedapoptosis. Conversely, depletion of Raf-1 from Raf-1+/+ mouseor human cells led to MST2 activation and apoptosis. The concomitantdepletion of both Raf-1 and MST2 prevented apoptosis.
1 The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK. 2 Sir Henry Wellcome Functional Genomics Facility, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK. 3 Max F. Perutz Laboratories, University Departments at the Vienna Biocenter, Department of Microbiology and Genetics, University of Vienna, Dr. Bohr Gasse 9, A-1030 Vienna, Austria.
* To whom correspondence should be addressed. E-mail: wkolch{at}beatson.gla.ac.uk
MST Kinases Monitor Actin Cytoskeletal Integrity and Signal via c-Jun N-Terminal Kinase Stress-Activated Kinase To Regulate p21Waf1/Cip1 Stability.
R. M. Densham, E. O'Neill, J. Munro, I. Konig, K. Anderson, W. Kolch, and M. F. Olson (2009)
Mol. Cell. Biol.
29, 6380-6390
|Abstract »|Full Text »|PDF »
From autoinhibition to inhibition in trans: the Raf-1 regulatory domain inhibits Rok-{alpha} kinase activity.
T. Niault, I. Sobczak, K. Meissl, G. Weitsman, D. Piazzolla, G. Maurer, F. Kern, K. Ehrenreiter, M. Hamerl, I. Moarefi, et al. (2009)
J. Cell Biol.
187, 335-342
|Abstract »|Full Text »|PDF »
A Short Hairpin DNA Analogous to miR-125b Inhibits C-Raf Expression, Proliferation, and Survival of Breast Cancer Cells.
M. H. Hofmann, J. Heinrich, G. Radziwil, and K. Moelling (2009)
Mol. Cancer Res.
7, 1635-1644
|Abstract »|Full Text »|PDF »
Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP).
BRAF V600E Disrupts AZD6244-Induced Abrogation of Negative Feedback Pathways between Extracellular Signal-Regulated Kinase and Raf Proteins.
B. B. Friday, C. Yu, G. K. Dy, P. D. Smith, L. Wang, S. N. Thibodeau, and A. A. Adjei (2008)
Cancer Res.
68, 6145-6153
|Abstract »|Full Text »|PDF »
Raf Signaling but not the ERK Effector SAP-1 Is Required for Regulatory T Cell Development.
J. E. Willoughby, P. S. Costello, R. H. Nicolas, N. J. Robinson, G. Stamp, F. Powrie, and R. Treisman (2007)
J. Immunol.
179, 6836-6844
|Abstract »|Full Text »|PDF »
Mitogen-Activated Protein Kinases in Heart Development and Diseases.
Grb10 and Active Raf-1 Kinase Promote Bad-dependent Cell Survival.
S. Kebache, J. Ash, M. G. Annis, J. Hagan, M. Huber, J. Hassard, C. L. Stewart, M. Whiteway, and A. Nantel (2007)
J. Biol. Chem.
282, 21873-21883
|Abstract »|Full Text »|PDF »
Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5.
L. Liu, Y. Cao, C. Chen, X. Zhang, A. McNabola, D. Wilkie, S. Wilhelm, M. Lynch, and C. Carter (2006)
Cancer Res.
66, 11851-11858
|Abstract »|Full Text »|PDF »
Inhibition of Cell Migration by Autophosphorylated Mammalian Sterile 20-Like Kinase 3 (MST3) Involves Paxillin and Protein-tyrosine Phosphatase-PEST.
T.-J. Lu, W.-Y. Lai, C.-Y. F. Huang, W.-J. Hsieh, J.-S. Yu, Y.-J. Hsieh, W.-T. Chang, T.-H. Leu, W.-C. Chang, W.-J. Chuang, et al. (2006)
J. Biol. Chem.
281, 38405-38417
|Abstract »|Full Text »|PDF »
A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation.
C. Rubiolo, D. Piazzolla, K. Meissl, H. Beug, J. C. Huber, A. Kolbus, and M. Baccarini (2006)
Blood
108, 152-159
|Abstract »|Full Text »|PDF »
Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma..
D. J. Panka, M. B. Atkins, and J. W. Mier (2006)
Clin. Cancer Res.
12, 2371s-2375s
|Abstract »|Full Text »|PDF »
Regulation and role of raf-1/b-raf heterodimerization..
L. K. Rushworth, A. D. Hindley, E. O'Neill, and W. Kolch (2006)
Mol. Cell. Biol.
26, 2262-2272
|Abstract »|Full Text »|PDF »
Role of the Tumor Suppressor RASSF1A in Mst1-Mediated Apoptosis..
H. J. Oh, K.-K. Lee, S. J. Song, M. S. Jin, M. S. Song, J. H. Lee, C. R. Im, J.-O. Lee, S. Yonehara, and D.-S. Lim (2006)
Cancer Res.
66, 2562-2569
|Abstract »|Full Text »|PDF »
The Raf Inhibitor BAY 43-9006 (Sorafenib) Induces Caspase-Independent Apoptosis in Melanoma Cells.
D. J. Panka, W. Wang, M. B. Atkins, and J. W. Mier (2006)
Cancer Res.
66, 1611-1619
|Abstract »|Full Text »|PDF »
Raf-1 sets the threshold of Fas sensitivity by modulating Rok-{alpha} signaling.
D. Piazzolla, K. Meissl, L. Kucerova, C. Rubiolo, and M. Baccarini (2005)
J. Cell Biol.
171, 1013-1022
|Abstract »|Full Text »|PDF »
Mechanism of von Hippel-Lindau Protein-Mediated Suppression of Nuclear Factor kappa B Activity.